UnitedHealth Group Financial Statements (UNH)
|
|
|
|
Report date
|
|
|
24.02.2023 |
31.12.2023 |
28.02.2024 |
27.02.2025 |
02.03.2026 |
|
05.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
324 162 |
371 622 |
371 622 |
400 278 |
447 567 |
|
449 713 |
|
Operating Income, bln rub |
|
|
28 435 |
32 358 |
32 358 |
32 287 |
18 964 |
|
18 835 |
|
EBITDA, bln rub |
? |
|
31 835 |
36 330 |
36 330 |
28 076 |
23 060 |
|
22 986 |
|
Net profit, bln rub |
? |
|
20 120 |
22 381 |
22 381 |
14 405 |
12 056 |
|
12 044 |
|
|
OCF, bln rub |
? |
|
26 206 |
29 068 |
29 068 |
24 204 |
19 697 |
|
23 153 |
|
CAPEX, bln rub |
? |
|
2 802 |
3 386 |
3 386 |
3 499 |
3 622 |
|
3 487 |
|
FCF, bln rub |
? |
|
23 404 |
25 682 |
25 682 |
20 705 |
16 075 |
|
19 666 |
|
Dividend payout, bln rub
|
|
|
5 991 |
6 761 |
6 761 |
7 533 |
7 916 |
|
8 009 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
29.8% |
30.2% |
30.2% |
52.3% |
65.7% |
|
66.5% |
|
|
OPEX, bln rub |
|
|
51 182 |
339 264 |
58 600 |
57 112 |
63 953 |
|
65 717 |
|
Cost of production, bln rub |
|
|
244 545 |
284 753 |
280 664 |
310 879 |
364 650 |
|
365 161 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
2 092 |
3 246 |
3 246 |
3 906 |
4 002 |
|
3 959 |
|
|
Assets, bln rub |
|
|
245 705 |
278 415 |
273 720 |
298 278 |
309 581 |
|
312 644 |
|
Net Assets, bln rub |
? |
|
77 772 |
88 756 |
88 756 |
92 658 |
94 110 |
|
103 895 |
|
Debt, bln rub |
|
|
57 623 |
67 435 |
67 435 |
76 904 |
78 389 |
|
77 917 |
|
Cash, bln rub |
|
|
27 911 |
29 628 |
29 628 |
29 113 |
28 121 |
|
31 229 |
|
Net debt, bln rub |
|
|
29 712 |
37 807 |
37 807 |
47 791 |
50 268 |
|
46 688 |
|
|
Ordinary share price, rub |
|
|
530.2 |
526.5 |
526.5 |
505.9 |
330.1 |
|
399.1 |
|
Number of ordinary shares, mln |
|
|
934.0 |
928.0 |
928.0 |
929.0 |
910.0 |
|
910.0 |
|
|
Market cap, bln rub |
|
|
495 188 |
488 564 |
488 564 |
469 944 |
300 400 |
|
363 208 |
|
EV, bln rub |
? |
|
524 900 |
526 371 |
526 371 |
517 735 |
350 668 |
|
409 896 |
|
Book value, bln rub |
|
|
-29 981 |
-30 170 |
-30 170 |
-37 344 |
-36 863 |
|
103 895 |
|
|
EPS, rub |
? |
|
21.5 |
24.1 |
24.1 |
15.5 |
13.2 |
|
13.2 |
|
FCF/share, rub |
|
|
25.1 |
27.7 |
27.7 |
22.3 |
17.7 |
|
21.6 |
|
BV/share, rub |
|
|
-32.1 |
-32.5 |
-32.5 |
-40.2 |
-40.5 |
|
114.2 |
|
|
EBITDA margin, % |
? |
|
9.82% |
9.78% |
9.78% |
7.01% |
5.15% |
|
5.11% |
|
Net margin, % |
? |
|
6.21% |
6.02% |
6.02% |
3.60% |
2.69% |
|
2.68% |
|
FCF yield, % |
? |
|
4.73% |
5.26% |
5.26% |
4.41% |
5.35% |
|
5.41% |
|
ROE, % |
? |
|
25.9% |
25.2% |
25.2% |
15.5% |
12.8% |
|
11.6% |
|
ROA, % |
? |
|
8.19% |
8.04% |
8.18% |
4.83% |
3.89% |
|
3.85% |
|
|
P/E |
? |
|
24.6 |
21.8 |
21.8 |
32.6 |
24.9 |
|
30.2 |
|
P/FCF |
|
|
21.2 |
19.0 |
19.0 |
22.7 |
18.7 |
|
18.5 |
|
P/S |
? |
|
1.53 |
1.31 |
1.31 |
1.17 |
0.67 |
|
0.81 |
|
P/BV |
? |
|
-16.5 |
-16.2 |
-16.2 |
-12.6 |
-8.15 |
|
3.50 |
|
EV/EBITDA |
? |
|
16.5 |
14.5 |
14.5 |
18.4 |
15.2 |
|
17.8 |
|
Debt/EBITDA |
|
|
0.93 |
1.04 |
1.04 |
1.70 |
2.18 |
|
2.03 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
0.86% |
0.91% |
0.91% |
0.87% |
0.81% |
|
0.78% |
|
| UnitedHealth Group shareholders |
